SPONSOR
Opus Genetics, Inc
Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Opus Genetics, Inc is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including ARB, BVMD, Autosomal-Dominant Bestrophinopathy, Best Vitelliform Macular Dystrophy.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Opus Genetics, Inc
How many clinical trials has Opus Genetics, Inc sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Opus Genetics, Inc, of which 1 are actively recruiting participants. These trials cover conditions including ARB, BVMD, Autosomal-Dominant Bestrophinopathy. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Opus Genetics, Inc research focus on?
Opus Genetics, Inc clinical trials span ARB, BVMD, Autosomal-Dominant Bestrophinopathy, Best Vitelliform Macular Dystrophy. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Opus Genetics, Inc clinical trial?
To participate in a Opus Genetics, Inc trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Opus Genetics, Inc trials with current recruitment status updated daily.
Clinical Trials by Opus Genetics, Inc
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology